DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Maitreya Medicare Limited — Board Meeting Intimation

NSE 1 hr ago·16 Oct 2026, 12:04 pm

Maitreya Medicare

Maitreya Medicare has announced that its board will meet on October 22, 2026, to review and approve the company's unaudited financial results for the first half of the fiscal year ending September 2026. This is a standard corporate procedure where the board reviews the company's performance before the data is made public.

For investors, this update is a key milestone as it provides the first glimpse into the company's operational health and financial trajectory for the current fiscal period. The results will help gauge the company's growth momentum and operational efficiency in the interim.

Investors should monitor the release of these results for any commentary on business performance and future outlook. The market will likely react to the figures, so keeping an eye on the official announcement is essential for understanding the stock's short-term direction.